rs1883414
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs1883414
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs2412971
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs2412971
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs6677604
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs6677604
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9275596
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9275596
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9357155
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9357155
|
|
|
0.800 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs3115573
|
|
|
0.800 |
GeneticVariation |
GWASCAT |
HLA has strongest association with IgA nephropathy in genome-wide analysis.
|
20595679 |
2010 |
rs3115573
|
|
|
0.800 |
GeneticVariation |
GWASDB |
HLA has strongest association with IgA nephropathy in genome-wide analysis.
|
20595679 |
2010 |
rs2856717
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9275224
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs9275424
|
|
|
0.700 |
GeneticVariation |
GWASDB |
Genome-wide association study identifies susceptibility loci for IgA nephropathy.
|
21399633 |
2011 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Endothelial nitric oxide synthase (eNOS) Glu298Asp single nucleotide polymorphism (SNP) genotype has been associated with a worse phenotype amongst patients with established heart failure and in patients with progression of their renal disease.
|
25612295 |
2015 |
rs699
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Genetic variants of ACE (Insertion/Deletion) and AGT (M268T) genes in patients with diabetes and nephropathy.
|
24737640 |
2014 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
NOS3 894G>T polymorphism is associated with progression of kidney disease and cardiovascular morbidity in type 2 diabetic patients: NOS3 as a modifier gene for diabetic nephropathy?
|
24603156 |
2013 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We genotyped three polymorphisms of eNOS (two SNPs: T-786C, G894T and one 27 VNTR) in T2DM patients with overt nephropathy (cases: n=320) and T2DM patients without overt nephropathy (controls: n=490), using validated PCR-RFLP assays.
|
23260854 |
2013 |
rs699
|
|
|
0.100 |
GeneticVariation |
BEFREE |
To assess the antiproteinuric response to multifactorial treatment based on high doses of angiotensin II receptor antagonists (ARBs) (olmesartan) in patients with non-diabetic proteinuric nephropathies, according to three renin-angiotensin system (RAS) polymorphisms: insertion/deletion of the angiotensin converting enzyme (ACE) gene, the angiotensinogen gene M235T and the angiotensin II type 1 receptor (AT1R) A1166C.
|
24241364 |
2013 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C allele for -786T>C and the T allele for 894G>T were significantly more frequent in diabetics with nephropathy than in diabetics without nephropathy (p<0.001; odds ratio [OR] and 95% confidence interval [CI] for the C allele=1.64 [1.24-2.17] and p<0.001; OR and 95% CI=1.7 [1.27-2.26] for the T allele).
|
22313046 |
2012 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
No associations between the -786T>C, the VNTR intron 4 a/b and the 894G>T (Glu298Asp) polymorphisms in the eNOS gene and renal disease were observed in type 2 diabetic Caucasian-Brazilians.
|
21255858 |
2011 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
A total of 3793 patients (DN) and 3161 controls (diabetes without nephropathy) for 4b/a, 2654 patients and 1993 controls for G894T and 1348 patients and 1175 controls for T786C were included in our analysis.
|
21084433 |
2011 |
rs699
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Association of the angiotensinogen M235T and APO E gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
|
21500980 |
2011 |
rs1799983
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The aim of this study was to evaluate the possible association between six SNPs (A-5466C, T-3892C, A-240T, C1237T, G2215A and A2350G) of the ACE gene and two SNPs (T-786C and G894T) of the eNOS gene with lupus nephropathy in a northern Chinese population.
|
20540812 |
2010 |